These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 9169664)

  • 1. Performance of prothrombin-proconvertin time as a monitoring test of oral anticoagulation therapy.
    Haraldsson HM; Onundarson PT; Einarsdóttir KA; Guõmundsdóttir BR; Pétursson MK; Pálsson K; Kristinsson A
    Am J Clin Pathol; 1997 Jun; 107(6):672-80. PubMed ID: 9169664
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The international normalized ratio (INR) for monitoring warfarin therapy: reliability and relation to other monitoring methods.
    Le DT; Weibert RT; Sevilla BK; Donnelly KJ; Rapaport SI
    Ann Intern Med; 1994 Apr; 120(7):552-8. PubMed ID: 8116992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fiix-prothrombin time versus standard prothrombin time for monitoring of warfarin anticoagulation: a single centre, double-blind, randomised, non-inferiority trial.
    Onundarson PT; Francis CW; Indridason OS; Arnar DO; Bjornsson ES; Magnusson MK; Juliusson SJ; Jensdottir HM; Vidarsson B; Gunnarsson PS; Lund SH; Gudmundsdottir BR
    Lancet Haematol; 2015 Jun; 2(6):e231-40. PubMed ID: 26688233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. During warfarin induction, the Fiix-prothrombin time reflects the anticoagulation level better than the standard prothrombin time.
    Jonsson PI; Letertre L; Juliusson SJ; Gudmundsdottir BR; Francis CW; Onundarson PT
    J Thromb Haemost; 2017 Jan; 15(1):131-139. PubMed ID: 27774726
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of plasma prothrombin and factor VII and urine prothrombin F1 concentrations in patients on long-term warfarin therapy and those in the initial phase.
    Weinstock DM; Chang P; Aronson DL; Kessler CM
    Am J Hematol; 1998 Mar; 57(3):193-9. PubMed ID: 9495368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. D-Dimer versus International Normalized Ratio of Prothrombin Time in Ischemic Stroke Patients Treated with Sufficient Warfarin.
    Yamamoto R; Nakae Y; Tanaka F; Johkura K
    J Stroke Cerebrovasc Dis; 2016 Jul; 25(7):1781-1785. PubMed ID: 27103270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reliability of the international normalized ratio for monitoring the induction phase of warfarin: comparison with the prothrombin time ratio.
    Johnston M; Harrison L; Moffat K; Willan A; Hirsh J
    J Lab Clin Med; 1996 Aug; 128(2):214-7. PubMed ID: 8765218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of native prothrombin antigen with the prothrombin time for monitoring oral anticoagulant prophylaxis.
    Kornberg A; Francis CW; Pellegrini VD; Gabriel KR; Marder VJ
    Circulation; 1993 Aug; 88(2):454-60. PubMed ID: 8339409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monitoring warfarin therapy in patients with lupus anticoagulants.
    Moll S; Ortel TL
    Ann Intern Med; 1997 Aug; 127(3):177-85. PubMed ID: 9245222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ignoring instead of chasing after coagulation factor VII during warfarin management: an interrupted time series study.
    Oskarsdottir AR; Gudmundsdottir BR; Jensdottir HM; Flygenring B; Palsson R; Onundarson PT
    Blood; 2021 May; 137(20):2745-2755. PubMed ID: 33512454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Critical role of factors II and X during coumarin anticoagulation and their combined measurement with a new Fiix-prothrombin time.
    Gudmundsdottir BR; Francis CW; Bjornsdottir AM; Nellbring M; Onundarson PT
    Thromb Res; 2012 Oct; 130(4):674-81. PubMed ID: 22225856
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reduced anticoagulation variability in patients on warfarin monitored with Fiix-prothrombin time associates with reduced thromboembolism: The Fiix-trial.
    Oskarsdóttir AR; Gudmundsdottir BR; Indridason OS; Lund SH; Arnar DO; Bjornsson ES; Magnusson MK; Jensdottir HM; Vidarsson B; Francis CW; Onundarson PT
    J Thromb Thrombolysis; 2017 May; 43(4):550-561. PubMed ID: 28214948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between international normalized ratio values, vitamin K-dependent clotting factor levels and in vivo prothrombin activation during the early and steady phases of oral anticoagulant treatment.
    D'Angelo A; Della Valle P; Crippa L; Fattorini A; Pattarini E; Viganò D'Angelo S
    Haematologica; 2002 Oct; 87(10):1074-80. PubMed ID: 12368163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care monitoring of oral anticoagulation therapy in children. Comparison of the CoaguChek XS system with venous INR and venous INR using an International Reference Thromboplastin preparation (rTF/95).
    Greenway A; Ignjatovic V; Summerhayes R; Newall F; Burgess J; DeRosa L; Monagle P
    Thromb Haemost; 2009 Jul; 102(1):159-65. PubMed ID: 19572081
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contributions of procoagulants and anticoagulants to the international normalized ratio and thrombin generation assay in patients treated with warfarin: potential role of protein Z as a powerful determinant of coagulation assays.
    Choi Q; Kim JE; Hyun J; Han KS; Kim HK
    Thromb Res; 2013 Jul; 132(1):e70-5. PubMed ID: 23769659
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of home prothrombin international ratio (PT-INR) management in children with mechanical prosthetic valves - Importance of individual correlations between laboratory and CoaguChek device PT-INRs.
    Ino N; Masutani S; Tanikawa S; Iwamoto Y; Saiki H; Ishido H; Tamura M; Senzaki H
    J Cardiol; 2018 Feb; 71(2):187-191. PubMed ID: 29066099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Warfarin initiation and monitoring with clotting factors II, VII, and X.
    Trask AS; Gosselin RC; Diaz JA; Dager WE
    Ann Pharmacother; 2004 Feb; 38(2):251-6. PubMed ID: 14742761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warfarin monitoring with viscoelastic haemostatic assays, thrombin generation, coagulation factors and correlations to Owren and Quick prothrombin time.
    Nilsson CU; Strandberg K; Reinstrup P
    Scand J Clin Lab Invest; 2018 Sep; 78(5):358-364. PubMed ID: 29792060
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suboptimal Anticoagulant Management in Japanese Patients with Nonvalvular Atrial Fibrillation Receiving Warfarin for Stroke Prevention.
    Hirano T; Kaneko H; Mishina S; Wang F; Morita S
    J Stroke Cerebrovasc Dis; 2017 Oct; 26(10):2102-2110. PubMed ID: 28532651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A modified method of prothrombin time/International Normalised Ratio determination in capillary blood and monitoring oral anticoagulant therapy.
    Berkovsky A; Sergeeva EV; Suvorov AV; Uljavova IS; Kachalova ND; Klimovich LG; Samsonova NN; Kozlov AA
    Clin Chem Lab Med; 2006; 44(10):1214-7. PubMed ID: 17032133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.